Products

What will AGI do for Amfepentorex?

This classification denotes an anorexiant with the molecular formula C15H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) OPE7BD4AAA, chemically known as phenethylamine, n,alpha-dimethyl-p-pentyl- but more generally known as amfepentorex, which bears US NIH Compound Identifier 71877. European Medicines Agency schedules Amfepentorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05416MIG. The term AMFEPENTOREX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). AMFEPENTOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule amfepentorex under HS 29214980 and SITC 51454. As of Q4 2014, AMFEPENTOREX remains US FDA's Preferred Term for this commodity. Amfepentorex bears US NLM identifiers UMLS ID C2346735 and NCI Concept Code C72178. SMILES: N(C(CC1CCC(CCCCC)CC1)C)C.

How AGI delivers it

Four ways AGI delivers for Amfepentorex

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amfepentorex, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amfepentorex, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amfepentorex connects

measured by

  • Assay Puritymodel
  • Chiral Enantiomeric Excessmodel
  • Chromatographic Impurity Profilemodel
  • Residual Solventmodel